Hematology TimesCombo may overcome TKI resistance in CMLJuly 31, 2015Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesInhibitor could treat range of hematologic disordersJuly 29, 2015CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic SyndromeCML
Hematology NewsCML patients die from comorbidities, not leukemiaJuly 17, 2015CMLLeukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Hematology TimesRadiation increases risk of death from CML, other leukemiasJuly 1, 2015Leukemia, Myelodysplasia, TransplantationALLCML
Hematology TimesNivolumab produces ‘dramatic’ responses in HLJune 25, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Hematology TimesDose reductions make ponatinib safer for CP-CMLJune 18, 2015Leukemia, Myelodysplasia, TransplantationCML
Hematology NewsEHA: Dasatinib gets early edge over imatinib in CMLJune 14, 2015Lymphoma & Plasma Cell DisordersCML
Hematology TimesMKIs can overcome resistance in CMLApril 29, 2015Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesDrug approved to treat CML, ALL in CanadaApril 7, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Hematology TimesStudy reveals potential strategy for treating CMLApril 2, 2015Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesIsrael approves ponatinib for CML, Ph+ ALLMarch 27, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Hematology TimesSkiing accident claims life of leukemia expertFebruary 26, 2015Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesEvolutionary findings may aid cancer drug developmentFebruary 20, 2015Leukemia, Myelodysplasia, TransplantationRelated IssuesCML
Hematology TimesApproved TKI could treat drug-resistant CML, ALLFebruary 11, 2015Leukemia, Myelodysplasia, TransplantationALLCML
Hematology TimesThough costly, blood cancer drugs appear cost-effectiveFebruary 8, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyCMLNon-Hodgkin Lymphoma
